Salivary antigens rPagSP02 and rPagSP06 are a reliable composite biomarker for evaluating exposure to Phlebotomus argentipes in Sri Lanka
Scientific Reports · 2024
DOI: 10.1038/s41598-024-77666-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports, 2024. Verfasst von Sachee Bhanu Piyasiri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Parasitology, Faculty of Medicine, University of Colombo, Colombo, 0800, Sri Lanka. Hauptthemen laut MEDLINE: Phlebotomus, Biomarkers, Salivary Proteins and Peptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Phlebotomus argentipes is the established vector of leishmaniasis in the Indian sub-continent. Antibodies to sand fly salivary antigens are biomarkers for vector-host exposure in leishmaniasis-endemic regions. Ph. argentipes transmits Leishmania donovani in Sri Lanka, primarily causing cutaneous leishmaniasis (CL). Our study compared the performance of salivary gland homogenate (SGH) from a lab-reared local strain of Ph. argentipes females to a composite recombinant salivary biomarker (rPagSP02 + rPagSP06) in a CL-endemic population. Sera from 546 healthy individuals, 30 CL patients, and 15 non-endemic individuals were collected. Western blot analysis of Ph. argentipes SGH identified immunogenic bands between 15 kDa and 67 kDa, with bands of predicted molecular weight ∼of 15 kDa (SP02) and ∼28-30 kDa (SP06) as the major antibody targets. Indirect ELISAs using SGH or rPagSP02 + rPagSP06 antigens showed high sensitivity (96.7%) and specificity (100%), detecting comparable seropositivity in endemic populations. rPagSP02 + rPagSP06 exhibited enhanced discriminatory ability, supported by a strong positive correlation (r = 0.869) with SGH. Our findings indicate that the composite rPagSP02 + rPagSP06 salivary biomarker effectively identifies Ph. argentipes exposure in individuals living in Sri Lanka, showing promising potential for use in surveillance. These findings should be further validated to confirm the epidemiological applications in leishmaniasis-endemic regions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Parasitology, Faculty of Medicine, University of Colombo, Colombo, 0800, Sri Lanka.
- Vector Molecular Biology Section, Laboratory of Malaria and Vector Research, NIAID, National Institutes of Health, Maryland, 20892, USA.
- Department of Parasitology, Faculty of Medicine, University of Colombo, Colombo, 0800, Sri Lanka. nadira@parasit.cmb.ac.lk.
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Piyasiri, S. B., Senanayake, S., Smaranayake, N., Doh, S., Iniguez, E., Valenzuela, J. G., Kamhawi, S., & Karunaweera, N. D. (2024). Salivary antigens rPagSP02 and rPagSP06 are a reliable composite biomarker for evaluating exposure to Phlebotomus argentipes in Sri Lanka. Scientific Reports. https://doi.org/10.1038/s41598-024-77666-2
Vancouver
Piyasiri SB, Senanayake S, Smaranayake N, Doh S, Iniguez E, Valenzuela JG, et al. Salivary antigens rPagSP02 and rPagSP06 are a reliable composite biomarker for evaluating exposure to Phlebotomus argentipes in Sri Lanka. Scientific Reports. 2024. doi:10.1038/s41598-024-77666-2
BibTeX
@article{Piyasiri2024,
author = {Piyasiri, Sachee Bhanu and Senanayake, Sanath and Smaranayake, Nilakshi and Doh, Serena and Iniguez, Eva and Valenzuela, Jesus Gilberto and Kamhawi, Shaden and Karunaweera, Nadira Darshani},
title = {Salivary antigens rPagSP02 and rPagSP06 are a reliable composite biomarker for evaluating exposure to Phlebotomus argentipes in Sri Lanka},
journal = {Scientific Reports},
year = {2024},
doi = {10.1038/s41598-024-77666-2}
}
EUVIMED